{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-28T15:37:53.748365+00:00","company":{"ticker":"GNVR","cik":1792941,"company_name":"Genvor Inc"},"pagination":{"limit":100,"returned":19,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"Evergreen Capital Management LLC","detail":"credit_facility","count":3,"first_seen":"2026-04-22T23:59:59+00:00","last_seen":"2026-06-22T20:15:22+00:00","evidence_fact_ids":[23478,201621,201622]},{"display_name":"Brio Advisory Group","detail":"other","count":1,"first_seen":"2026-04-22T23:59:59+00:00","last_seen":"2026-04-22T23:59:59+00:00","evidence_fact_ids":[23479]}]},"facts":[{"fact_type":"material_agreement","fact_key":"28e95ee82bc02acf75c76a7c0368ec63e36975b4","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2026-06-22T20:15:22+00:00","payload":{"action":"entry","agreement_name":"Warrant","agreement_type":"other","counterparty":"Evergreen Capital Management LLC","effective_date":"2026-06-17","item_codes_triggered":["1.01"],"value_text":null},"claim":"Genvor Inc entered into Warrant with Evergreen Capital Management LLC (effective 2026-06-17).","evidence_excerpt":"In connection with the funding of the second and third Tranches, on June 17, 2026, the Company issued to Evergreen a five-year warrant (the “Warrant”) to purchase up to 300,000 shares (the “Warrant Shares”) of the Company’s common stock at an exercise price of $1.00 per share, subject to adjustment.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-070627","anchor_url":"https://secwatch.observer/filing/0001213900-26-070627#claim-28e95ee82bc02acf75c76a7c0368ec63e36975b4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000121390026070627/0001213900-26-070627-index.htm"},{"fact_type":"material_agreement","fact_key":"a9124d51d9ee1bf78e125da0597e2a3847122f5b","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2026-06-22T20:15:22+00:00","payload":{"action":"amendment","agreement_name":"Letter Agreement","agreement_type":"equity_purchase","counterparty":"Evergreen Capital Management LLC","effective_date":"2026-06-17","item_codes_triggered":["1.01"],"value_text":null},"claim":"Genvor Inc amended Letter Agreement with Evergreen Capital Management LLC (effective 2026-06-17).","evidence_excerpt":"On June 17, 2026 (the “Effective Date”), the Company and Evergreen entered into a side letter agreement (the “Letter Agreement”), pursuant to which, among things: (i) Evergreen’s registration rights, including its piggyback registration rights, were deleted; (ii) the number of warrants to be issued was increased from 600,000 to up to 1,200,000; (iii) Evergreen accelerated the funding of the second and third Tranches such that, on the Effective Date, the Company received gross proceeds of $333,334; and (iv) the fourth Tranche in the amount of $166,667 (the “Fourth Tranche”) may be funded at the option of Evergreen, provided that Evergreen’s option to fund the Fourth Tranche will expire upon the maturity date of the Note.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-070627","anchor_url":"https://secwatch.observer/filing/0001213900-26-070627#claim-a9124d51d9ee1bf78e125da0597e2a3847122f5b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000121390026070627/0001213900-26-070627-index.htm"},{"fact_type":"executive_change","fact_key":"c90e9e8823","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2026-05-21T20:15:19+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-05-18","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Donald Kalkofen was appointed as Chief Financial Officer at Genvor Inc.","evidence_excerpt":"appointed Donald Kalkofen as the Company’s Chief Financial Officer effective as of May 18, 2026.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001903596-26-000235","anchor_url":"https://secwatch.observer/filing/0001903596-26-000235#claim-c90e9e8823","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000190359626000235/0001903596-26-000235-index.htm"},{"fact_type":"governance_change","fact_key":"b896466753e6ed7806c66f3e1121165c3b3b46f2","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2026-05-11T21:28:52+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2026-05-05","item_codes_triggered":["5.03"],"summary_text":"Filed certificate of designation creating Series C Preferred Stock, not an amendment to articles of incorporation or bylaws."},"claim":"Genvor Inc: Filed certificate of designation creating Series C Preferred Stock, not an amendment to articles of incorporation or bylaws (effective 2026-05-05).","evidence_excerpt":"On May 5, 2026, Genvor Incorporated (“ Genvor ”) filed with the State of Nevada a certificate of designation (the “ Designation ”) designating the rights and preferences of Genvor’s Series C Preferred Stock","confidence":0.4,"filing_url":"https://secwatch.observer/filing/0001903596-26-000204","anchor_url":"https://secwatch.observer/filing/0001903596-26-000204#claim-b896466753e6ed7806c66f3e1121165c3b3b46f2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000190359626000204/0001903596-26-000204-index.htm"},{"fact_type":"material_agreement","fact_key":"2a74a2a275e8a3b22d2e22ca39feff98f2c43520","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2026-04-22T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Advisory Agreement","agreement_type":"other","counterparty":"Brio Advisory Group","effective_date":"2026-04-16","item_codes_triggered":["1.01"],"value_text":"shares of preferred stock valued at $300,000 per Tranche, up to $1,200,000 in aggregate"},"claim":"Genvor Inc entered into Advisory Agreement with Brio Advisory Group valued at shares of preferred stock valued at $300,000 per Tranche, up to $1,200,000 in aggregate (effective 2026-04-16).","evidence_excerpt":"On April 16, 2026, the Company also entered into an Advisory Agreement (the “ Advisory Agreement ”) with Brio Advisory Group (the “ Consultant ”), pursuant to which the Consultant will provide the Company advisory services in connection with strategic initiatives, capitalization, financial and other planning, due diligence, financing efforts, and an Exchange Listing, and the Company will issue to the Consultant shares of preferred stock which will be valued as follows: (i) $300,000 per Tranche ($1,200,000 in the aggregate if all four Tranches of funding under the Note are funded to the Company) at the time of the Exchange Listing, or (ii) if there is no Exchange Listing within one year of the date of the Advisory Agreement, that will convert into $300,000 of Company common stock per Tranche based on the 5-day average closing price at such time, but in no event at less than $1.00 per share.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001903596-26-000160","anchor_url":"https://secwatch.observer/filing/0001903596-26-000160#claim-2a74a2a275e8a3b22d2e22ca39feff98f2c43520","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000190359626000160/0001903596-26-000160-index.htm"},{"fact_type":"material_agreement","fact_key":"bef1b579fac577e0d6e12a72d16353d4645fd78a","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2026-04-22T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Securities Purchase Agreement","agreement_type":"credit_facility","counterparty":"Evergreen Capital Management LLC","effective_date":"2026-04-16","item_codes_triggered":["1.01"],"value_text":"up to $800,000 principal amount for aggregate purchase price of up to $666,668"},"claim":"Genvor Inc entered into Securities Purchase Agreement with Evergreen Capital Management LLC valued at up to $800,000 principal amount for aggregate purchase price of up to $666,668 (effective 2026-04-16).","evidence_excerpt":"Effective April 16, 2026, Genvor Incorporated (the “ Company ”) entered into a securities purchase agreement (the “ SPA ”) with Evergreen Capital Management LLC (“ Evergreen ”), pursuant to which the Company sold, and Evergreen purchased, (i) a convertible promissory note in the aggregate principal amount of up to $800,000 (the “ Note ”), and (ii) warrants to purchase up to 600,000 shares of Company common stock (the “ Warrants ”), for an aggregate purchase price of up to $666,668 (the “ Purchase Price ”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001903596-26-000160","anchor_url":"https://secwatch.observer/filing/0001903596-26-000160#claim-bef1b579fac577e0d6e12a72d16353d4645fd78a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000190359626000160/0001903596-26-000160-index.htm"},{"fact_type":"executive_change","fact_key":"ab176c27e0","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2024-11-13T23:59:59+00:00","payload":{"action":"elected","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-11-12","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Chad Pawlak, Sr. was elected as Director at Genvor Inc.","evidence_excerpt":"On November 12, 2024, Chad Pawlak, Sr. was elected as a Board of Directors of Genvor Incorporated (the “Company”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001903596-24-000651","anchor_url":"https://secwatch.observer/filing/0001903596-24-000651#claim-ab176c27e0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000190359624000651/0001903596-24-000651-index.htm"},{"fact_type":"executive_change","fact_key":"aed851124f","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2024-10-22T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2024-08-07","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Judith S. Miller resigned as Director at Genvor Inc.","evidence_excerpt":"On August 7, 2024, Judith S. Miller resigned as a member of the Board of Directors of Genvor Incorporated (the “Company”).","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001903596-24-000622","anchor_url":"https://secwatch.observer/filing/0001903596-24-000622#claim-aed851124f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000190359624000622/0001903596-24-000622-index.htm"},{"fact_type":"executive_change","fact_key":"753c2450ba","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2024-06-03T23:59:59+00:00","payload":{"action":"terminated","action_category":"departure","departure_tone":"not_disclosed","effective_date":"2024-05-29","interim":true,"role":"Interim Chief Financial Officer and Chief Business Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Judith S. Miller was terminated as Interim Chief Financial Officer and Chief Business Officer at Genvor Inc.","evidence_excerpt":"On May 29, 2024, Judith S. Miller was terminated as Interim Chief Financial Officer and Chief Business Officer of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-022265","anchor_url":"https://secwatch.observer/filing/0001493152-24-022265#claim-753c2450ba","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000149315224022265/0001493152-24-022265-index.htm"},{"fact_type":"auditor_change","fact_key":"6146a4b245228047605788f55ddf4c91864986a2","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2024-03-21T23:59:59+00:00","payload":{"action":"engagement","auditor_name":"Novogradac & Company LLP","disagreement_text":null,"effective_date":"2024-03-20","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Genvor Inc engaged Novogradac & Company LLP as its auditor.","evidence_excerpt":"On or about March 20, 2024, the Company engaged Novogradac & Company LLP (the “ New Accounting Firm ”) of Plantation, Florida, as its new independent registered public accounting firm.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-010701","anchor_url":"https://secwatch.observer/filing/0001493152-24-010701#claim-6146a4b245228047605788f55ddf4c91864986a2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000149315224010701/0001493152-24-010701-index.htm"},{"fact_type":"auditor_change","fact_key":"17c8557e6c292b1e6a5ef3c13f939f93b0722cd0","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2024-03-21T23:59:59+00:00","payload":{"action":"dismissal","auditor_name":"Turner, Stone & Company, LLP","disagreement_text":null,"effective_date":"2024-03-17","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":"Novogradac & Company LLP"},"claim":"Genvor Inc dismissed Turner, Stone & Company, LLP as its auditor.","evidence_excerpt":"On March 17, 2024, Genvor Incorporated (the “ Company ”) dismissed Turner, Stone & Company, LLP (the “ Former Accounting Firm ”) as its independent registered public accounting firm.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-010701","anchor_url":"https://secwatch.observer/filing/0001493152-24-010701#claim-17c8557e6c292b1e6a5ef3c13f939f93b0722cd0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000149315224010701/0001493152-24-010701-index.htm"},{"fact_type":"executive_change","fact_key":"9430920904","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"role_change","departure_tone":"routine","effective_date":"2024-01-17","interim":false,"role":"scientific advisor","role_category":"other_named_officer","successor_name":"Dr. Jesse Jaynes","successor_named":true},"claim":"Dr. Clayton Yates was appointed as scientific advisor at Genvor Inc.","evidence_excerpt":"Dr. Clayton Yates resigned as Chief Scientific Officer of the Company and was appointed as a scientific advisor for the Company","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-003418","anchor_url":"https://secwatch.observer/filing/0001493152-24-003418#claim-9430920904","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000149315224003418/0001493152-24-003418-index.htm"},{"fact_type":"executive_change","fact_key":"6ab23d92ab","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-17","interim":false,"role":"Chief Scientific Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Dr. Jesse Jaynes was appointed as Chief Scientific Officer at Genvor Inc.","evidence_excerpt":"Dr. Jesse Jaynes was appointed as the Chief Scientific Officer of the Company","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-003418","anchor_url":"https://secwatch.observer/filing/0001493152-24-003418#claim-6ab23d92ab","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000149315224003418/0001493152-24-003418-index.htm"},{"fact_type":"executive_change","fact_key":"04ca510edc","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"role_change","departure_tone":"routine","effective_date":"2024-01-17","interim":true,"role":"member of the Board, Chief Business Officer, and Interim Chief Financial Officer","role_category":"cfo","successor_name":"Chad Pawlak","successor_named":true},"claim":"Judith S. Miller was appointed as member of the Board, Chief Business Officer, and Interim Chief Financial Officer at Genvor Inc.","evidence_excerpt":"Judith S. Miller resigned as the Company’s Interim Chief Executive Officer and was appointed as a member of the Company’s Board of Directors (the “ Board ”), as the Chief Business Officer of the Company, and as the Interim Chief Financial Officer of the Company","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-003418","anchor_url":"https://secwatch.observer/filing/0001493152-24-003418#claim-04ca510edc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000149315224003418/0001493152-24-003418-index.htm"},{"fact_type":"executive_change","fact_key":"b15ce34437","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2024-01-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-17","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Chad Pawlak was appointed as Chief Executive Officer at Genvor Inc.","evidence_excerpt":"Chad Pawlak was appointed as Chief Executive Officer of Genvor Incorporated","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-24-003418","anchor_url":"https://secwatch.observer/filing/0001493152-24-003418#claim-b15ce34437","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000149315224003418/0001493152-24-003418-index.htm"},{"fact_type":"auditor_change","fact_key":"71bc126ead4478674c1e925a8f424b5a753ae29c","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2024-01-18T23:59:59+00:00","payload":{"action":"non_reliance","auditor_name":null,"disagreement_text":null,"effective_date":"2024-01-09","item_codes_triggered":["4.02"],"non_reliance_signal":"non_reliance","successor_auditor_name":null},"claim":"Genvor Inc reported that prior financial statements should not be relied upon.","evidence_excerpt":"the Company’s financial statements for the periods ending September 30, 2022, December 31, 2022, March 31, 2023, and June 30, 2023, should no longer be relied upon because the Company had incorrectly recorded a liability for what it believed was a required extension payment associated with its USDA CRADA research contract","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-002926","anchor_url":"https://secwatch.observer/filing/0001493152-24-002926#claim-71bc126ead4478674c1e925a8f424b5a753ae29c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000149315224002926/0001493152-24-002926-index.htm"},{"fact_type":"auditor_change","fact_key":"dd903a90e78f9f0295308e4c7518f738d35ed96a","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2024-01-16T23:59:59+00:00","payload":{"action":"non_reliance","auditor_name":null,"disagreement_text":null,"effective_date":"2024-01-09","item_codes_triggered":["4.02"],"non_reliance_signal":"non_reliance","successor_auditor_name":null},"claim":"Genvor Inc reported that prior financial statements should not be relied upon.","evidence_excerpt":"On January 9, 2024, the independent certifying accountant of Genvor Incorporated (the “ Company ”) notified the Company that the Company’s financial statements for the periods ending September 30, 2022, December 31, 2022, March 31, 2023, and June 30, 2023, should no longer be relied upon because the Company had incorrectly recorded a liability for what it believed was a required extension payment associated with its USDA CRADA research contract as of September 30, 2022.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-24-002459","anchor_url":"https://secwatch.observer/filing/0001493152-24-002459#claim-dd903a90e78f9f0295308e4c7518f738d35ed96a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000149315224002459/0001493152-24-002459-index.htm"},{"fact_type":"executive_change","fact_key":"287b16b276","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2023-07-06T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-06-20","interim":true,"role":"Interim Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Judith S. Miller was appointed as Interim Chief Executive Officer at Genvor Inc.","evidence_excerpt":"Judith S. Miller was appointed as Interim Chief Executive Officer of the Company","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-23-023622","anchor_url":"https://secwatch.observer/filing/0001493152-23-023622#claim-287b16b276","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000149315223023622/0001493152-23-023622-index.htm"},{"fact_type":"executive_change","fact_key":"b55e154b44","cik":1792941,"ticker":"GNVR","company_name":"Genvor Inc","filed_at":"2023-07-06T23:59:59+00:00","payload":{"action":"terminated","action_category":"departure","departure_tone":"termination","effective_date":"2023-06-20","interim":false,"role":null,"role_category":"other_named_officer","successor_name":"Judith S. Miller","successor_named":true},"claim":"Bradley White was terminated as other_named_officer at Genvor Inc.","evidence_excerpt":"On June 20, 2023, Bradley White was terminated as an officer of Genvor Incorporated","confidence":0.8,"filing_url":"https://secwatch.observer/filing/0001493152-23-023622","anchor_url":"https://secwatch.observer/filing/0001493152-23-023622#claim-b55e154b44","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1792941/000149315223023622/0001493152-23-023622-index.htm"}]}